State of the art in cystic fibrosis pharmacology—Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti‐methicillin‐resistant Staphylococcus aureus (MRSA) antibiotics-Reference-Cited by-同舟云学术

State of the art in cystic fibrosis pharmacology—Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti‐methicillin‐resistant Staphylococcus aureus (MRSA) antibiotics

Published:2019-10-14 Issue:1 Volume:55 Page:33-57
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Epps Quovadis J.¹,Epps Kevin L.²,Young David C.³⁴^ORCID,Zobell Jeffery T.⁵⁶^ORCID

Affiliation:

1. Florida Agricultural and Mechanical University College of Pharmacy and Pharmaceutical Sciences Jacksonville Florida

2. Department of PharmacyThe Mayo Clinic Jacksonville Florida

3. L.S. Skaggs Pharmacy InstituteUniversity of Utah College of Pharmacy Salt Lake City Utah

4. University of Utah Adult Cystic Fibrosis Center Salt Lake City Utah

5. Department of PharmacyIntermountain Primary Children's Hospital Salt Lake City Utah

6. Primary Children's Cystic Fibrosis Center Salt Lake City Utah

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24537

Reference82 articles.

1. Management of Pulmonary Disease in Patients with Cystic Fibrosis

2. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

3. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary

4. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis

5. Forest Pharmaceuticals Inc. Teflaro approved package labeling. May2016.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis;Infectious Disease Clinics of North America;2024-03

2. Antibacterial Agents;Principles and Practice of Pediatric Infectious Diseases;2023

3. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis;Clinics in Chest Medicine;2022-12

4. Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review;International Journal of Antimicrobial Agents;2021-09

5. The indispensable role of pharmacy services and medication therapy management in cystic fibrosis;Pediatric Pulmonology;2021-08-11